Impact of a Palliative Care Model on Patient Knowledge and Attitudes
A Palliative Care Model Impact on Knowledge and Attitudes
NA · Hunter College of City University of New York · NCT06860932
This study tests if a video about palliative care can help people with Multiple Sclerosis understand their treatment options better than just reading a pamphlet.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Hunter College of City University of New York (other) |
| Locations | 2 sites (New York, New York and 1 other locations) |
| Trial ID | NCT06860932 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of a palliative care decision aid video on patients with Multiple Sclerosis (MS) compared to a control group receiving written information. Participants will be randomly assigned to either view the video or read an informational sheet, and their goals-of-care preferences will be assessed at baseline, immediately after the intervention, and three months later. The study aims to measure changes in treatment preferences, knowledge, and decision-making preparation. It utilizes a structured approach to ensure balanced representation across demographics.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-65 diagnosed with MS, NMOSD, or anti-MOG for at least two years who can communicate in English.
Not a fit: Patients with significant cognitive impairment or major depressive disorder may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance patient understanding and decision-making regarding palliative care options for those with chronic progressive illnesses.
How similar studies have performed: Other studies have shown positive outcomes using similar palliative care decision aids, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with MS, NMOSD, or anti-MOG, at least 2 years after their diagnosis. * Aged 18-65 * Speak English since all instruments are available in English. Exclusion Criteria: * Visually impaired (note, hearing impaired is not an exclusion criterion as the video is closed captioned). * Psychological state not appropriate for PC discussions as determined by the Patient Health Questionnaire 9 (PHQ9). * A score of 11 or higher, indicative of major depressive disorder, will be referred to immediate management and excluded from the study. * Unable to participate in PC discussions due to cognitive impairment as determined by the Processing Speed Test (PST) score below -1.5 Z score.
Where this trial is running
New York, New York and 1 other locations
- Judith Jaffe Multiple Sclerosis Center — New York, New York, United States (RECRUITING)
- Hunter College — New York, New York, United States (RECRUITING)
Study contacts
- Study coordinator: Aliza Ben-Zacharia, PhD
- Email: ab1288@hunter.cuny.edu
- Phone: 6462262616
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Multiple Sclerosis, MS